DrugPatentWatch Database Preview

Drugs in Development Information for Anlotinib

US Patents	4
International Patents	41
US Patent Applications	7
WIPO Patent Applications	11
Japanese Patent Applications	0
Clinical Trial Progress	Phase 2 (2019-01-01)
Vendors	18

Subscribe to access the full database, or try a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Anlotinib	➤ Sign Up	Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	➤ Sign Up
Anlotinib	➤ Sign Up	Spiro substituted compounds as angiogenesis inhibitors		➤ Sign Up
Anlotinib	➤ Sign Up	Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)meth- yl)cyclopropanamine, its crystalline form and its salts	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	➤ Sign Up
Anlotinib	➤ Sign Up	Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same	Advenchen Laboratories Nanjing Ltd (Jiangsu, CN) Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Jiangsu, CN)	➤ Sign Up
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration

Subscribe to access the full database, or try a Free Trial
Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Anlotinib	Australia	2016257816	2035-05-04	➤ Sign Up
Anlotinib	Brazil	112017023639	2035-05-04	➤ Sign Up
Anlotinib	Canada	2984444	2035-05-04	➤ Sign Up
Anlotinib	China	107771078	2035-05-04	➤ Sign Up
Anlotinib	Eurasian Patent Organization	201792355	2035-05-04	➤ Sign Up
Anlotinib	European Patent Office	3291814	2035-05-04	➤ Sign Up
Anlotinib	Japan	2018515482	2035-05-04	➤ Sign Up
Drugname	Country	Document Number	Estimated Expiration	Related US Patent